Scholars Central

Conference abstractPublished 17 Aug 2015

Development and clinical translation of nanoliposomal chemotherapeutics

Authors: Daryl C. Drummond

Merrimack Pharmaceuticals, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Highly stabilized sustained released liposomal formulations of chemotherapeutic drugs have been developed and currently being evaluated in the clinic. These novel drug delivery systems provide for extended circulation lifetimes, preferential distribution to sites of solid tumors, and the ability to mitigate certain dose limiting toxicities when administered as the free form of the drug. Our lead agent, nal-IRI or nanoliposomal Irinotecan (MM-398) has recently completed a successful Phase III clinical trial in gemcitabine refractory pancreatic cancer. A second ErbB2-antibody targeted immunoliposomal doxorubicin is being studied in a pivotal Phase II trial in ErbB2-overexpressing breast cancer patients. The development of these and similar drugs requires the careful optimization of a variety of parameters related to the encapsulated drug, physicochemical properties of the drug carrier system itself, drug entrapment and retention strategies, and the introduction of targeting ligands. Here we will discuss both the engineering considerations as well as the translation consideration for this promising class of drug carrier systems.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectNanotechnology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Daryl C. Drummond”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels